𝔖 Bobbio Scriptorium

✦ LIBER ✦

Imiquimod 2.5% and 3.75% applied daily for up to 8 weeks to treat external genital warts

✍ Scribed by D. Baker; D. Ferris; S. Tyring; K. Ault; S. Levy; T. Liu; G. Barry; J. Wu

Book ID: 116382624
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 58 KB
Volume: 82
Category: Article
ISSN: 0010-7824
DOI: 10.1016/j.contraception.2010.04.129

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Imiquimod 2.5% and 3.75% for the treatme

Imiquimod 2.5% and 3.75% for the treatment of external genital warts: Additional insights into efficacy

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Imiquimod 2.5% and 3.75% for the treatme

Imiquimod 2.5% and 3.75% for the treatment of external genital warts: Assessment of safety in 981 randomized patients

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Imiquimod 2.5% and 3.75% for the treatme

Imiquimod 2.5% and 3.75% for the treatment of external genital warts: Assessment of efficacy in 981 randomized patients

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Imiquimod 2.5% and 3.75% for the treatme

Imiquimod 2.5% and 3.75% for the treatment of external genital warts: Sex differences in a study of 981 randomized patients

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Imiquimod 2.5% and 3.75% for the treatme

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

✍ C. William Hanke; Kenneth R. Beer; Eggert Stockfleth; Jason Wu; Theodore Rosen; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 548 KB

Imiquimod 2.5% and 3.75% for the treatme

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

✍ Neil Swanson; William Abramovits; Brian Berman; James Kulp; Darrell S. Rigel; Sh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 467 KB